RXRB
Retinoic acid receptor RXR-beta
Also known as: H-2RIIBP, NR2B2, RCoR-1, RXR-beta, RXRB_HUMAN, RXRbeta
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P28702
- Gene
- RXRB
- Ensembl
- ENSG00000204231
- Chromosome
- 6
- Canonical length
- 533 aa
- Protein class
- Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the retinoid X receptor (RXR) family of nuclear receptors which are involved in mediating the effects of retinoic acid (RA). The encoded protein forms homodimers with the retinoic acid, thyroid hormone, and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. This gene lies within the major histocompatibility complex (MHC) class II region on chromosome 6. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]
Canonical amino-acid sequenceUniProt
533 residues, UniProt reviewed canonical sequence.
>P28702|RXRB
1 MSWAARPPFL PQRHAAGQCG PVGVRKEMHC GVASRWRRRR PWLDPAAAAA AAVAGGEQQT
61 PEPEPGEAGR DGMGDSGRDS RSPDSSSPNP LPQGVPPPSP PGPPLPPSTA PSLGGSGAPP
121 PPPMPPPPLG SPFPVISSSM GSPGLPPPAP PGFSGPVSSP QINSTVSLPG GGSGPPEDVK
181 PPVLGVRGLH CPPPPGGPGA GKRLCAICGD RSSGKHYGVY SCEGCKGFFK RTIRKDLTYS
241 CRDNKDCTVD KRQRNRCQYC RYQKCLATGM KREAVQEERQ RGKDKDGDGE GAGGAPEEMP
301 VDRILEAELA VEQKSDQGVE GPGGTGGSGS SPNDPVTNIC QAADKQLFTL VEWAKRIPHF
361 SSLPLDDQVI LLRAGWNELL IASFSHRSID VRDGILLATG LHVHRNSAHS AGVGAIFDRV
421 LTELVSKMRD MRMDKTELGC LRAIILFNPD AKGLSNPSEV EVLREKVYAS LETYCKQKYP
481 EQQGRFAKLL LRLPALRSIG LKCLEHLFFF KLIGDTPIDT FLMEMLEAPH QLALocalizationUniProt · AlphaFold · HPA
Whether an antibody against RXRB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 43 nTPM
- skeletal muscle: 41 nTPM
- spleen: 37 nTPM
- thyroid gland: 36 nTPM
- cerebral cortex: 35 nTPM
- blood vessel: 34 nTPM
Single-cell type
- oligodendrocytes: 20 nCPM
- bergmann glia: 19 nCPM
- brain excitatory neurons: 18 nCPM
- brain inhibitory neurons: 17 nCPM
- oligodendrocyte progenitor cells: 17 nCPM
- astrocytes: 17 nCPM
Immune cell
- basophil: 2.3 nTPM
- eosinophil: 1.7 nTPM
- memory CD4 T-cell: 1.3 nTPM
- memory CD8 T-cell: 1.3 nTPM
- gdT-cell: 1.1 nTPM
- naive CD4 T-cell: 1.1 nTPM
Brain region
- hypothalamus: 4.1 nTPM
- midbrain: 1.4 nTPM
- spinal cord: 1.4 nTPM
- cerebral cortex: 1.3 nTPM
- thalamus: 1.3 nTPM
- white matter: 1.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.42
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac muscle cell proliferation
- cell differentiation
- cellular response to retinoic acid
- hormone-mediated signaling pathway
- in utero embryonic development
- maternal placenta development
- mRNA transcription by RNA polymerase II
- nervous system development
- positive regulation of bone mineralization
- positive regulation of DNA-templated transcription
- positive regulation of transcription by RNA polymerase II
- positive regulation of vitamin D receptor signaling pathway
- retinoic acid receptor signaling pathway
- ventricular cardiac muscle cell differentiation
Molecular functions
- chromatin DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- nuclear receptor activity
- nuclear steroid receptor activity
- retinoic acid-responsive element binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Retinoid X receptor/HNF4
- Nuclear hormone receptor, ligand-binding domain
- Zinc finger, nuclear hormone receptor-type
- Nuclear hormone receptor
- Zinc finger, NHR/GATA-type
- Nuclear hormone receptor-like domain superfamily
- Nuclear hormone receptor family NR2 subfamily
- Ligand-binding domain of nuclear hormone receptor
- Double treble clef zinc finger, C4 type
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RXRB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RXRB as an antibody target. Whether an autoantibody or antibody against RXRB could matter depends on whether native RXRB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RXRB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RXRB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...